This Edition
ARTICLE | Clinical News
VEL-0230: Phase Ia start
WIR Staff
October 1, 2007 7:00 AM UTC
In 1Q08, Velcura plans to begin an open-label, dose-escalation Phase Ia trial of oral VEL-0230. ...